title: Biogen's aducanumab raises hope that Alzheimer's can be treated at its source.
authors.forename: Krishna Rutvij
authors.initials: KR
authors.lastname: Patel
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D058225:Plaque, Amyloid / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D016229:Amyloid beta-Peptides; D061067:Antibodies, Monoclonal, Humanized; D015507:Drugs, Investigational; C000600266:aducanumab